Pancreatic Cancer and Synchronous Liver Metastases Resection Following Neoadjuvant FOLFIRINOX
Conditions: Pancreas Adenocarcinoma; Pancreas Metastases; Pancreas Cancer Interventions: Procedure: Pancreatic resection and non-anatomic liver resections. Sponsors: Laval University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Motivational Interviewing in the Management of Non Alcoholic Fatty Liver Disease
Conditions: Non-Alcoholic Fatty Liver Disease Interventions: Behavioral: Motivational Interview; Behavioral: Placebo Sponsors: Madunil Anuk Niriella Active, not recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
Radiological Characterization of Pulmonary Involvement in Patients With Hematological Diseases
Conditions: Hematologic Diseases Interventions: Diagnostic Test: Complete Blood Count; Diagnostic Test: C-reactive protein; Diagnostic Test: O2 saturation; Diagnostic Test: Serum ferritin and D-dimer; Diagnostic Test: Liver and renal function tests; Diagnostic Test: Lactate dehydrogenase; Diagnostic Test: coronavirus (SARS-CoV-2) swab; Radiation: CT chest Sponsors: New Valley University Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
A Randomized, Multicenter Phase II Basket Study of Hypofractionated Radiotherapy/Stereotactic Body Radiotherapy Followed by Immunotherapy-Based Systemic Therapy +/- L. Rhamnosus M9 for the First-Line Treatment of Advanced Digestive System Malignancies.
Conditions: Gastroesophageal Junction Adenocarcinoma; Liver Cancer Stage IV; Biliary Tract Cancer; Pancreatic Adenocarcinoma; Colorectal Cancer; Gastric Cancer Interventions: Radiation: Hypofractionated radiotherapy/SBRT （5-8 Gy/fx，3-5 fx）; Drug: Anti-PD-1 monoclonal antibody; Drug: Oxaliplatin and Capecitabine; Drug: Anti-VEGF 15mg/kg; Drug: Anti-VEGF 7.5mg/kg; Drug: Gemcitabine and Cisplatin; Drug: Gemcitabine and Albumin paclitaxel Sponsors: Zhejiang Cancer Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 5, 2024 Category: Research Source Type: clinical trials
AGED Diagnostics Liver Disease Assessment
Conditions: NASH With Fibrosis; NAFLD; Healthy Interventions: Diagnostic Test: AGED Multiple Target Assay in Healthy Controls; Diagnostic Test: AGED Multiple Target Assay in NAFLD Participants; Diagnostic Test: AGED Multiple Target Assay in Fibrosis Participants Sponsors: Active Genomes Expressed Diagnostics, Corp; Arizona Clinical Trials; Walter Reed National Military Medical Center Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Precision Nutrition to Improve Cardiometabolic Health With Dietary (Poly)Phenols
Conditions: Individual Variability in (Poly)Phenol Metabolism; Cardiometabolic Health; Personalized Dietary Intervention; Obesity Interventions: Other: Personalized Dietary Plan; Dietary Supplement: Oral (Poly)phenol Challenge Test (OPCT); Other: General Dietary Advice Sponsors: University of Parma; Azienda Ospedaliero-Universitaria di Parma; University of Milan; Foundation for Liver Research; National Research Council, Spain Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 4, 2024 Category: Research Source Type: clinical trials
Incidence & Predictive Factors of Recompensation in Children With Decompensated Cirrhosis as Per the Baveno VII Criteria
Conditions: Decompensated Cirrhosis Interventions: Other: Other Sponsors: Institute of Liver and Biliary Sciences, India Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Low-dose Arginine-vasopressin Supplementation on Post-transplant Acute Kidney Injury After Liver Transplantation (AVENIR Trial)
Conditions: Acute Kidney Injury Post Liver Transplantation Interventions: Drug: Arginine vasopressin; Drug: Norepinephrine Sponsors: Assistance Publique - H ôpitaux de Paris Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Early Detection of Liver Cancer by QUS
Conditions: Hepatocellular Carcinoma; Liver Cancer Interventions: Diagnostic Test: Quantitative Ultrasound; Diagnostic Test: B-mode Ultrasound; Diagnostic Test: Magnetic Resonance Imaging; Diagnostic Test: Liver Biopsy Sponsors: Centre hospitalier de l ' Universit é de Montréal (CHUM); Centre de Recherche du Centre Hospitalier de l ' Universit é de Montréal; Canadian Institutes of Health Research (CIHR) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
Digital Pathology and AI for Liver Outcomes in MASLD
Conditions: Metabolic Dysfunction-associated Steatotic Liver Disease Interventions: Diagnostic Test: Digital Pathology FibroNest Phenotypic Fibrosis Composite Score (Ph-FCS) Sponsors: PharmaNest, Inc; Chinese University of Hong Kong; University of Edinburgh; University of Seville; Imperial College London; Icahn School of Medicine at Mount Sinai; Fundacio Clinic Barcelona Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
A First-in-Human Study to Learn About How BAY3630942 is Distributed and Processed Inside the Body When Given After BAY3547922 and How Safe it is in People With Liver Cancer
Conditions: Hepatocellular Carcinoma (HCC) Interventions: Drug: BAY3630942; Drug: BAY3547922 Sponsors: Bayer Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 3, 2024 Category: Research Source Type: clinical trials
First Patient Dosed in Phase 2a Clinical Trial of a First-in-Class Regenerative Cell Therapy for Patients with End-Stage Liver Disease
PITTSBURGH, April 2, 2024. LyGenesis, a clinical-stage biotechnology company developing cell therapies for large unmet medical needs, announced today that the first patient has been dosed in their Phase 2a clinical trial... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - April 2, 2024 Category: Pharmaceuticals Source Type: clinical trials
Early Detection of Advanced Adenomas and Colorectal Cancer
Conditions: Colorectal Cancer; Colorectal Neoplasms; Colorectal Polyp; Colorectal Adenocarcinoma; Colorectal Disorders; Colorectal Dysplasia; Colorectal Cancer Stage I; Colorectal Cancer Stage II; Colorectal Cancer Stage III; Colorectal Cancer Stage IV; Colorectal Neoplasms Malignant; Colorectal Serrated Adenocarcinoma; Colorectal Adenoma With Severe Dysplasia; Colorectal Adenoma With Mild Dysplasia; Colorectal Adenoma With Moderate Dysplasia; Colorectal Adenoma and Carcinoma 1; Colorectal Adenomatous Polyp; Colorectal Adenocarcinoma Metastatic in the Liver Interventions: Diagnostic Test: DENEB Sponsors: City of Hope Medic...
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
Acute Kidney Injury in Patients With Liver Cirrhosis
Conditions: Acute Kidney Injury in Patients With Liver Cirrhosis Interventions: Diagnostic Test: serum creatinine Sponsors: Sohag University Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
The Optimal Number of Fiducial Marker for Stereotactic Body Radiotherapy
Conditions: Lung Cancer; Liver Cancer; Pancreatic Cancer; Renal Cell Carcinoma Interventions: Radiation: SBRT Sponsors: Peking University Third Hospital Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2024 Category: Research Source Type: clinical trials
